Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WA › Spokane › NPI 1144471715
Hospital

Providence Health & Services - Wa

Providence Health & Services - Wa was paid $78.83M by Medicaid between Jan 2018 and Dec 2024, across 578 billing codes. Its largest line is 99283, emergency room visit (moderate) — 14% of everything it billed.

33Billing provider infoPROVIDENCE HEALTH & SERVICES - WA
SPOKANE, WA 99204
33aNPI1144471715assigned 10/01/2008
33bProvider typePsychiatric Hospital Unit
28Total paid$78.83M
24GClaims2,606,659
24DCodes billed578
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Psychiatric Hospital Unit providers in Washington

Rank by total paid#2 of 11
Median peer was paid$15K
This provider vs. median5,378×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018407,738$11.43M
2019402,219$11.25M
2020356,389$9.82M
2021397,711$11.40M
2022375,226$11.86M
2023362,218$11.64M
2024incomplete305,158$11.42M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 14% 81,085 75,055 $10.73M
96361 Intravenous infusion, hydration; each additional hour 12% 29,513 26,406 $9.33M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 7.4% 62,205 57,989 $5.84M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 5.5% 54,547 50,444 $4.32M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 4.8% 37,564 25,772 $3.77M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 4.2% 13,145 12,890 $3.35M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2.7% 19,236 15,090 $2.10M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 2.4% 4,526 4,459 $1.90M
70450 Computed tomography, head or brain; without contrast material 2.4% 12,807 12,159 $1.88M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2.4% 23,475 21,739 $1.86M
74177 Computed tomography, abdomen and pelvis; with contrast material 2.1% 10,177 9,872 $1.68M
S9480 Intensive outpatient psychiatric services, per diem 2.0% 3,393 600 $1.58M
566 more codes
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 2.0% 6,745 $1.56M
44970 1.9% 450 $1.54M
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study 1.9% 4,095 $1.53M
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.8% 10,272 $1.38M
99281 Emergency department visit for the evaluation and management, self-limited or minor 1.2% 6,668 $982K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.2% 9,597 $928K
54161 <1% 530 $699K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 4,300 $695K
67311 <1% 339 $669K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 2,347 $655K
H2012 Behavioral health day treatment, per hour <1% 1,882 $652K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 1,391 $646K
93304 <1% 1,564 $622K
93458 <1% 671 $588K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 6,092 $585K
93308 <1% 2,003 $584K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 1,630 $574K
93325 <1% 9,113 $548K
70551 Magnetic resonance imaging, brain; without contrast material <1% 2,740 $543K
80053 Comprehensive metabolic panel <1% 105,893 $542K
43235 <1% 1,404 $504K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography <1% 2,356 $485K
95819 <1% 2,182 $473K
G0378 Hospital observation service, per hour <1% 25,892 $470K
71275 Computed tomographic angiography, chest, with contrast material <1% 3,219 $465K
87631 <1% 9,149 $456K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 15,473 $447K
12011 <1% 1,761 $396K
12001 <1% 1,698 $363K
58571 <1% 148 $362K
96415 <1% 1,280 $337K
95816 <1% 1,278 $293K
36430 <1% 1,700 $289K
93017 <1% 2,707 $277K
76770 <1% 2,253 $266K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 3,106 $259K
93971 <1% 2,355 $198K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 472 $186K
80048 Basic metabolic panel (calcium, ionized) <1% 36,255 $164K
70498 <1% 1,510 $160K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 14,996 $158K
J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg <1% 96 $142K
12002 <1% 768 $137K
95700 <1% 741 $137K
36415 Collection of venous blood by venipuncture <1% 72,723 $131K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 122,466 $128K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 2,975 $128K
96367 <1% 2,695 $127K
70496 <1% 1,566 $117K
76830 Ultrasound, transvaginal <1% 1,516 $115K
93975 <1% 1,880 $111K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,935 $111K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 13,890 $108K
84484 <1% 25,999 $105K
78264 <1% 284 $105K
84443 Thyroid stimulating hormone (TSH) <1% 18,049 $101K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 3,335 $97K
83880 <1% 11,453 $97K
96450 <1% 232 $93K
43244 <1% 186 $91K
87040 <1% 12,250 $85K
20680 <1% 67 $83K
87086 Culture, bacterial; quantitative colony count, urine <1% 26,505 $78K
90870 <1% 420 $77K
74230 <1% 915 $77K
77072 <1% 1,554 $75K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 12,732 $72K
95714 <1% 213 $69K
J1745 Injection, infliximab, excludes biosimilar, 10 mg <1% 57 $69K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 5,063 $68K
71046 Radiologic examination, chest; 2 views <1% 21,513 $67K
76937 <1% 1,306 $67K
70491 <1% 338 $64K
83735 <1% 29,403 $63K
93321 <1% 3,988 $59K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 8,324 $59K
76870 <1% 617 $59K
83605 <1% 12,764 $58K
70486 <1% 1,608 $58K
47562 <1% 24 $53K
88307 <1% 2,605 $53K
J3490 Unclassified drugs <1% 4,346 $52K
83970 <1% 2,646 $51K
88142 <1% 3,766 $51K
82784 <1% 6,307 $50K
76801 <1% 772 $49K
86140 <1% 20,660 $47K
74240 <1% 461 $46K
G0249 Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the home and reporting of test results to physician; testing not occurring more frequently than once a week; testing materials, billing units of service include 4 tests <1% 1,951 $46K
84145 <1% 5,505 $45K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 2,941 $45K
90715 <1% 2,650 $44K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 41,390 $44K
97161 <1% 1,290 $43K
80050 General health panel <1% 6,540 $43K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 988 $42K
93320 <1% 4,121 $42K
72125 Computed tomography, cervical spine; without contrast material <1% 4,241 $42K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 2,421 $40K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 3,853 $40K
29125 <1% 223 $39K
97162 <1% 1,375 $39K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 39,106 $37K
87641 <1% 3,176 $36K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 3,639 $36K
87186 <1% 12,353 $36K
74018 <1% 6,495 $36K
49083 <1% 74 $36K
80069 <1% 6,227 $36K
85027 <1% 26,916 $34K
87486 <1% 3,363 $34K
87581 <1% 3,362 $34K
87077 <1% 10,116 $34K
97166 <1% 1,222 $33K
96375 Therapeutic injection; each additional sequential IV push <1% 34,404 $33K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 4,286 $31K
80061 Lipid panel <1% 5,260 $30K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 2,027 $29K
43237 <1% 123 $29K
96409 <1% 2,108 $28K
94729 <1% 778 $28K
82570 <1% 7,780 $28K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 14 $28K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,739 $27K
85379 <1% 5,575 $27K
10060 <1% 147 $26K
36561 <1% 27 $25K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 172 $25K
84439 <1% 6,090 $25K
71045 Radiologic examination, chest; single view <1% 19,728 $24K
85652 <1% 12,325 $22K
J9312 Injection, rituximab, 10 mg <1% 17 $22K
81001 <1% 55,454 $22K
85610 <1% 34,205 $21K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 5,062 $21K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 55 $20K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 183 $20K
80143 <1% 4,947 $20K
82728 <1% 5,487 $20K
87505 <1% 261 $19K
83036 Hemoglobin; glycosylated (A1C) <1% 5,548 $19K
10061 <1% 93 $19K
76882 <1% 217 $18K
88342 <1% 3,651 $18K
97165 <1% 576 $18K
76825 <1% 249 $18K
59025 Fetal non-stress test <1% 100 $17K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 658 $17K
84305 <1% 1,298 $17K
85007 <1% 4,653 $17K
80306 <1% 15,832 $16K
84156 <1% 6,448 $16K
84146 <1% 1,199 $16K
83550 <1% 3,671 $16K
P9040 Red blood cells, leukocytes reduced, irradiated, each unit <1% 58 $16K
86803 <1% 2,705 $15K
87088 <1% 6,683 $15K
P9047 Infusion, albumin (human), 25%, 50 ml <1% 75 $15K
87081 <1% 3,441 $15K
86780 <1% 1,497 $15K
29848 <1% 14 $15K
86850 <1% 9,863 $15K
83516 <1% 2,445 $15K
82533 <1% 1,324 $15K
84100 <1% 10,162 $14K
80197 <1% 2,317 $14K
93531 <1% 12 $14K
87070 <1% 7,268 $14K
86923 <1% 1,277 $14K
80164 <1% 1,961 $13K
31624 <1% 40 $13K
86364 <1% 1,978 $13K
94060 <1% 345 $12K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 12,501 $12K
43259 <1% 44 $12K
82962 <1% 45,174 $12K
84403 <1% 1,101 $12K
87205 <1% 8,230 $12K
80076 <1% 2,444 $11K
83690 <1% 26,005 $11K
G0379 Direct admission of patient for hospital observation care <1% 524 $11K
95812 <1% 29 $11K
87075 <1% 4,937 $11K
84702 <1% 7,042 $11K
29105 <1% 92 $10K
87340 <1% 3,283 $10K
83540 <1% 4,077 $10K
86900 <1% 9,978 $10K
80179 <1% 4,688 $10K
92960 <1% 42 $10K
88185 <1% 288 $10K
83001 <1% 1,083 $9K
86901 <1% 10,539 $9K
43752 <1% 21 $9K
83002 <1% 1,019 $9K
82607 <1% 1,580 $9K
70487 <1% 74 $9K
36573 <1% 15 $9K
71250 <1% 225 $9K
81025 <1% 21,976 $9K
94660 <1% 63 $9K
83874 <1% 1,958 $9K
76827 <1% 263 $8K
94726 <1% 268 $8K
85014 <1% 5,178 $8K
82105 <1% 810 $8K
86480 <1% 548 $8K
51600 <1% 24 $7K
74019 <1% 2,860 $7K
82670 <1% 563 $7K
P9016 Red blood cells, leukocytes reduced, each unit <1% 56 $7K
95951 <1% 37 $7K
92611 <1% 742 $7K
82043 <1% 3,334 $7K
82785 <1% 685 $6K
86160 <1% 1,063 $6K
82550 <1% 4,158 $6K
25605 <1% 13 $6K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 1,406 $6K
83520 <1% 1,113 $6K
49452 <1% 12 $6K
J1439 Injection, ferric carboxymaltose, 1 mg <1% 16 $6K
43242 <1% 14 $5K
90686 <1% 648 $5K
82565 <1% 2,285 $5K
85576 <1% 550 $5K
74174 <1% 38 $5K
72141 <1% 38 $5K
80178 <1% 670 $5K
82077 <1% 12,685 $5K
86762 <1% 1,281 $5K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 4,187 $5K
88304 <1% 2,283 $5K
85730 <1% 7,665 $5K
73130 <1% 2,508 $5K
84436 <1% 457 $5K
96376 <1% 14,102 $5K
94770 <1% 78 $5K
73562 <1% 1,473 $5K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 55,970 $5K
88313 <1% 903 $4K
J2704 Injection, propofol, 10 mg <1% 34,911 $4K
86376 <1% 359 $4K
84112 <1% 616 $4K
82248 <1% 1,947 $4K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 332 $4K
97535 Self-care/home management training, each 15 minutes <1% 373 $4K
99152 <1% 3,451 $4K
88341 <1% 1,051 $4K
87147 <1% 2,071 $4K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 33,442 $4K
43762 <1% 39 $4K
86592 <1% 1,078 $4K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 20,034 $4K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 33 $4K
43247 <1% 12 $4K
85018 <1% 4,167 $4K
72100 <1% 1,752 $4K
84550 <1% 2,118 $4K
86704 <1% 1,190 $4K
86361 <1% 282 $4K
72040 <1% 1,194 $4K
87511 <1% 399 $4K
C1874 Stent, coated/covered, with delivery system <1% 43 $4K
85049 <1% 1,286 $3K
99153 Mod sedat endo service >5yrs <1% 3,269 $3K
86706 <1% 1,055 $3K
10120 <1% 12 $3K
93880 <1% 74 $3K
73630 <1% 2,352 $3K
74328 <1% 126 $3K
86038 <1% 885 $3K
87799 <1% 399 $3K
86003 <1% 413 $3K
73610 <1% 2,592 $3K
82805 <1% 757 $3K
84460 <1% 1,359 $3K
88184 <1% 581 $3K
73030 <1% 2,287 $3K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 25,157 $3K
82746 <1% 744 $3K
92585 <1% 13 $3K
81003 <1% 10,412 $3K
J7120 Ringers lactate infusion, up to 1000 cc <1% 21,804 $3K
J1170 Injection, hydromorphone, up to 4 mg <1% 25,645 $3K
84703 <1% 7,372 $3K
85046 <1% 2,709 $3K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 26,557 $2K
89230 <1% 91 $2K
83615 <1% 2,450 $2K
95957 <1% 34 $2K
82247 <1% 525 $2K
73090 <1% 2,076 $2K
82950 <1% 707 $2K
86800 <1% 138 $2K
87184 <1% 1,033 $2K
C8930 Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision <1% 50 $2K
82610 <1% 260 $2K
82977 <1% 852 $2K
87497 <1% 179 $2K
93312 <1% 13 $2K
M0247 Intravenous infusion, sotrovimab, includes infusion and post administration monitoring <1% 16 $2K
73502 <1% 1,389 $2K
82803 <1% 4,227 $2K
74455 <1% 12 $2K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 27,164 $2K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 23,404 $2K
73700 <1% 42 $2K
87899 <1% 1,188 $2K
J1815 Injection, insulin, per 5 units <1% 10,124 $2K
87481 <1% 418 $2K
87046 <1% 632 $2K
87210 <1% 2,192 $2K
J7030 Infusion, normal saline solution , 1000 cc <1% 24,024 $2K
73110 <1% 1,586 $2K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 220 $2K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 2,781 $2K
73552 <1% 765 $2K
82150 <1% 1,085 $2K
73590 <1% 1,999 $2K
A9541 Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries <1% 648 $2K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 8,351 $2K
87209 <1% 202 $2K
87493 <1% 399 $2K
73560 <1% 1,170 $2K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 2,713 $2K
89051 <1% 1,801 $2K
82626 <1% 107 $1K
82947 <1% 1,995 $1K
83519 <1% 167 $1K
Q0247 Injection, sotrovimab, 500 mg <1% 16 $1K
J0690 Injection, cefazolin sodium, 500 mg <1% 15,083 $1K
82140 <1% 836 $1K
73140 <1% 697 $1K
87522 Neg quan hep c or qual rna <1% 75 $1K
84295 <1% 1,731 $1K
86231 <1% 253 $1K
81015 <1% 396 $1K
J7050 Infusion, normal saline solution, 250 cc <1% 30,204 $1K
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 7,000 $1K
99157 <1% 89 $1K
87116 <1% 178 $1K
96368 <1% 240 $1K
87045 <1% 617 $1K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 8,336 $1K
88112 <1% 240 $1K
J2270 Injection, morphine sulfate, up to 10 mg <1% 10,796 $1K
97802 <1% 27 $1K
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) <1% 892 $1K
73080 <1% 949 $993.48
86360 <1% 70 $964.69
C1769 Guide wire <1% 6,798 $956.74
82951 <1% 117 $948.05
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 2,267 $932.31
J9370 Vincristine sulfate, 1 mg <1% 1,271 $917.77
93970 <1% 13 $883.35
Q9957 Injection, perflutren lipid microspheres, per ml <1% 3,249 $862.45
87177 <1% 201 $855.76
72126 <1% 233 $852.95
A9585 Injection, gadobutrol, 0.1 ml <1% 3,220 $796.79
87634 <1% 828 $779.96
85384 <1% 1,299 $753.23
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 4,108 $752.39
99155 <1% 46 $739.73
82024 <1% 41 $715.73
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 1,740 $699.27
82330 <1% 529 $686.74
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,248 $658.23
96417 <1% 15 $642.00
80175 <1% 98 $639.55
81002 <1% 2,297 $637.41
84450 <1% 394 $625.87
C1889 Implantable/insertable device, not otherwise classified <1% 579 $614.89
86147 <1% 53 $604.47
C2617 Stent, non-coronary, temporary, without delivery system <1% 238 $571.87
87338 <1% 106 $570.25
84402 <1% 105 $567.32
87176 <1% 337 $563.38
86200 <1% 121 $562.42
88275 <1% 18 $562.07
0399T <1% 121 $558.29
85670 <1% 429 $557.56
84132 <1% 2,459 $549.09
84478 <1% 281 $541.02
86225 <1% 184 $534.12
84480 <1% 94 $528.68
89060 <1% 233 $526.65
86708 <1% 199 $525.46
82438 <1% 67 $514.34
J1756 Injection, iron sucrose, 1 mg <1% 65 $497.23
J3370 Injection, vancomycin hcl, 500 mg <1% 5,857 $492.45
D0220 Intraoral - periapical first radiographic image <1% 70 $489.14
99156 <1% 13 $470.72
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 5,663 $466.40
D1206 Topical application of fluoride varnish <1% 93 $457.78
82310 <1% 173 $454.74
85240 <1% 92 $453.54
36591 <1% 105 $450.62
86317 <1% 72 $440.73
J1644 Injection, heparin sodium, per 1000 units <1% 10,109 $432.13
82627 <1% 62 $428.04
82553 <1% 57 $423.72
84445 <1% 15 $419.48
86431 <1% 142 $412.66
88271 <1% 12 $399.80
A9270 Non-covered item or service <1% 34,314 $394.42
94668 <1% 19 $390.72
87206 <1% 619 $381.32
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 8,231 $372.87
86039 <1% 62 $363.79
C1751 Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) <1% 1,218 $354.85
94010 <1% 14 $345.65
82010 <1% 680 $342.20
72170 <1% 339 $341.25
J7060 5% dextrose/water (500 ml = 1 unit) <1% 1,616 $340.28
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 719 $336.79
94727 <1% 15 $335.19
73070 <1% 461 $330.57
86235 <1% 45 $328.41
73564 <1% 124 $325.73
J2310 Injection, naloxone hydrochloride, per 1 mg <1% 41 $321.89
83655 <1% 26 $312.78
84446 <1% 28 $302.91
88237 <1% 12 $292.94
D0150 Comprehensive oral evaluation - new or established patient <1% 69 $279.68
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 3,846 $276.02
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 2,238 $268.10
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 2,657 $264.71
J0280 Injection, aminophyllin, up to 250 mg <1% 730 $262.91
83993 <1% 30 $236.45
J9045 Injection, carboplatin, 50 mg <1% 16 $236.13
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 23,027 $233.97
J1650 Injection, enoxaparin sodium, 10 mg <1% 7,176 $233.15
90670 <1% 12 $224.33
D0230 Intraoral - periapical each additional radiographic image <1% 59 $217.17
80177 <1% 42 $215.29
84520 <1% 976 $200.08
80074 <1% 39 $194.93
87015 <1% 230 $184.54
J1580 Injection, garamycin, gentamicin, up to 80 mg <1% 975 $180.87
84481 <1% 16 $177.66
84144 <1% 25 $175.17
73060 <1% 211 $174.36
83010 <1% 13 $172.01
88311 <1% 137 $170.05
88264 <1% 12 $166.80
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 3,174 $165.37
84466 <1% 41 $153.22
80202 <1% 16 $141.30
J3475 Injection, magnesium sulfate, per 500 mg <1% 4,682 $140.28
J0780 Injection, prochlorperazine, up to 10 mg <1% 1,673 $138.72
89055 <1% 45 $131.15
90656 <1% 17 $124.34
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 3,093 $118.61
87806 <1% 1,391 $111.63
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 218 $111.32
51798 <1% 25 $109.37
J2550 Injection, promethazine hcl, up to 50 mg <1% 2,952 $104.36
84590 <1% 13 $103.08
70250 <1% 12 $98.01
C9113 Injection, pantoprazole sodium, per vial <1% 2,938 $95.63
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 9,899 $91.25
86334 <1% 13 $77.53
73000 <1% 58 $70.98
J1245 Injection, dipyridamole, per 10 mg <1% 775 $67.58
84165 <1% 14 $66.24
82435 <1% 794 $65.92
88300 <1% 62 $63.19
86258 <1% 15 $62.86
72072 <1% 63 $61.02
J9260 Injection, methotrexate sodium, 50 mg <1% 419 $58.06
86015 <1% 12 $52.80
87807 <1% 107 $51.97
84075 <1% 14 $50.93
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 272 $49.26
J2060 Injection, lorazepam, 2 mg <1% 6,268 $47.68
86665 <1% 25 $43.87
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm <1% 3,861 $43.78
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 281 $43.09
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 17 $41.03
87430 <1% 29 $39.60
86037 <1% 13 $38.56
88108 <1% 49 $38.27
J1940 Injection, furosemide, up to 20 mg <1% 1,669 $37.33
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 973 $37.23
87102 <1% 52 $36.89
J0694 Injection, cefoxitin sodium, 1 gm <1% 146 $36.80
36416 <1% 308 $36.00
J1953 Injection, levetiracetam, 10 mg <1% 419 $35.42
86308 <1% 67 $34.48
87181 <1% 13 $26.68
81050 <1% 15 $26.46
Q0177 Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 2,635 $25.97
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 52 $25.80
J8540 Dexamethasone, oral, 0.25 mg <1% 1,945 $25.04
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 1,043 $25.00
76010 <1% 36 $23.34
88312 <1% 13 $20.77
86664 <1% 13 $19.53
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 3,378 $18.93
J1630 Injection, haloperidol, up to 5 mg <1% 881 $16.44
J3480 Injection, potassium chloride, per 2 meq <1% 2,142 $13.02
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 15 $13.02
85246 <1% 13 $11.96
J3411 Injection, thiamine hcl, 100 mg <1% 1,804 $11.75
84157 <1% 28 $8.26
82945 <1% 38 $8.10
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 391 $3.44
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 1,044 $3.28
C1766 Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away <1% 229 $3.25
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 766 $2.91
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 23 $2.20
J0744 Injection, ciprofloxacin for intravenous infusion, 200 mg <1% 87 $1.87
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 1,257 $1.00
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 25 $0.90
Q0244 Injection, casirivimab and imdevimab, 1200 mg <1% 13 $0.03
J1920 Injection, labetalol hydrochloride, 5 mg 0% 190 $0.00
G8987 Self care functional limitation, current status, at therapy episode outset and at reporting intervals 0% 238 $0.00
J1790 Injection, droperidol, up to 5 mg 0% 915 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 0% 1,722 $0.00
C1726 Catheter, balloon dilatation, non-vascular 0% 151 $0.00
S2900 Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) 0% 99 $0.00
73600 0% 14 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 0% 88 $0.00
J1836 Injection, metronidazole, 10 mg 0% 353 $0.00
S9981 Medical records copying fee, administrative 0% 17 $0.00
J0456 Injection, azithromycin, 500 mg 0% 74 $0.00
J2305 Injection, nitroglycerin, 5 mg 0% 129 $0.00
J7999 Compounded drug, not otherwise classified 0% 166 $0.00
96411 0% 39 $0.00
G8988 Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 216 $0.00
43264 0% 12 $0.00
J0360 Injection, hydralazine hcl, up to 20 mg 0% 106 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 15 $0.00
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 0% 13 $0.00
S9982 Medical records copying fee, per page 0% 28 $0.00
72020 0% 61 $0.00
J1805 Injection, esmolol hydrochloride, 10 mg 0% 12 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 218 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 367 $0.00
0100U 0% 33 $0.00
J2359 Injection, olanzapine, 0.5 mg 0% 123 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 310 $0.00
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg 0% 457 $0.00
93356 0% 671 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 329 $0.00
J0692 Injection, cefepime hydrochloride, 500 mg 0% 264 $0.00
S0080 Injection, pentamidine isethionate, 300 mg 0% 157 $0.00
J3415 Injection, pyridoxine hcl, 100 mg 0% 208 $0.00
J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg 0% 568 $0.00
71100 0% 12 $0.00
G8989 Self care functional limitation, discharge status, at discharge from therapy or to end reporting 0% 28 $0.00
J2004 Injection, lidocaine hcl with epinephrine, 1 mg 0% 101 $0.00
C1758 Catheter, ureteral 0% 12 $0.00
J1956 Injection, levofloxacin, 250 mg 0% 55 $0.00
J2720 Injection, protamine sulfate, per 10 mg 0% 24 $0.00
J0137 Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg 0% 13 $0.00
G2215 Take-home supply of nasal naloxone; 2-pack of 4mg per 0.1 ml nasal spray (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure 0% 16 $0.00
J3371 Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg 0% 38 $0.00
C1760 Closure device, vascular (implantable/insertable) 0% 12 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 299 $0.00
Q9958 High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml 0% 13 $0.00
J0736 Injection, clindamycin phosphate, 300 mg 0% 16 $0.00
51702 0% 16 $0.00
C2625 Stent, non-coronary, temporary, with delivery system 0% 13 $0.00
C1776 Joint device (implantable) 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialANDERSON, DONALD (ASSISTANT SECRETARY FOR ENROLLMENT)
Same official

Other billing entities under ANDERSON, DONALD

Full network →
ProviderLocationPaid
Providence Health & Services WashingtonAnchorage, AK$161.45M
Kadlec Regional Medical CenterRichland, WA$151.60M
Swedish EdmondsEdmonds, WA$30.06M
ST. Joseph Health Northern California, LLCEureka, CA$28.68M
Providence Health System Southern CaliforniaTorrance, CA$27.29M
Providence Health System - Southern CaliforniaSan Pedro, CA$24.26M
Providence Health & Services - WashingtonTukwila, WA$21.98M
Swedish Health ServicesSeattle, WA$21.06M
Providence Health & Services WashingtonKodiak, AK$11.39M
Swedish Health ServicesSeattle, WA$11.08M
ST. Joseph Health Northern California, LLCFortuna, CA$8.55M
Collabria CareNapa, CA$8.20M
Providence Health & Services OregonSeaside, OR$8.01M
Providence Health & Services- WashingtonSpokane, WA$8.01M
Hospice of Lubbock INCLubbock, TX$6.48M
Providence Saint John's Health CenterSanta Monica, CA$5.52M
Methodist Hospital LevellandLevelland, TX$4.55M
Collabria CareNapa, CA$4.05M
Methodist Hospital LevellandLevelland, TX$4.01M
Methodist Hospital Plainview TexasPlainview, TX$4.00M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.